{"id":"NCT00885365","sponsor":"Chiesi Farmaceutici S.p.A.","briefTitle":"A Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®","officialTitle":"A Multicentre, Multinational, Open-Label, Randomised, Parallel Group Clinical Trial of Tobrineb®/Actitob®/Bramitob® (Tobramycin Solution for Nebulisation, 300mg Twice Daily in 4mL Unit Dose Vials) Compared to TOBI® in the Treatment of Patients With Cystic Fibrosis and Chronic Infection With Pseudomonas Aeruginosa","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-04","primaryCompletion":"2010-04","completion":"2010-05","firstPosted":"2009-04-21","resultsPosted":"2014-06-20","lastUpdate":"2018-06-27"},"enrollment":324,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Cystic Fibrosis"],"interventions":[{"type":"DRUG","name":"tobramycin / Bramitob","otherNames":["Bramitob","Tobrineb","Actitob","Bethkis"]},{"type":"DRUG","name":"tobramycin / TOBI","otherNames":["TOBI"]}],"arms":[{"label":"Bramitob","type":"EXPERIMENTAL"},{"label":"TOBI","type":"ACTIVE_COMPARATOR"}],"summary":"The objectives of the study are to demonstrate that Tobrineb®/Actitob®/Bramitob® is non-inferior to TOBI® in the primary efficacy variable, forced expiratory volume in one second (FEV1) percent of predicted normal, and to compare the safety in participants with cystic fibrosis and chronic infection of the lungs with Pseudomonas aeruginosa.","primaryOutcome":{"measure":"Change From Baseline to End of the Treatment Period of Forced Expiratory Volume in 1 Second (FEV1), Expressed as Percentage of Predicted Normal","timeFrame":"Day 0 (baseline), Week 4","effectByArm":[{"arm":"Bramitob","deltaMin":6.99,"sd":9.52},{"arm":"TOBI","deltaMin":7.51,"sd":9.63}],"pValues":[{"comp":"OG000 vs OG001","p":"0.640"}]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":10},"locations":{"siteCount":44,"countries":["Czechia","France","Germany","Hungary","Poland","Russia","Spain","Ukraine"]},"refs":{"pmids":["24464974"],"seeAlso":["https://www.clinicaltrialsregister.eu/ctr-search/search?query=CMA-0631-PR-0010"]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":156},"commonTop":["Cough"]}}